Erez Alroy - 10 Jun 2026 Form 4 Insider Report for Nano-X Imaging Ltd. (NNOX)

Reporting relationship: Director
Issuer ticker: NNOX
Reported as of: 10 Jun 2026
Net transaction value: -$1,119
SEC form: 4
Accepted by SEC: 15 Jun 2026, 16:05:24 UTC
Prior SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Marina Gofman Feler, attorney-in-fact

Key filing fact

Erez Alroy filed Form 4 for Nano-X Imaging Ltd. (NNOX) on 15 Jun 2026.

Key facts

This page summarizes Erez Alroy's Form 4 filing for Nano-X Imaging Ltd. (NNOX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 16:05.

Change

Previous filing in this sequence was filed on 07 Apr 2026.
Current net transaction value: -$1,119.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970040 Primary reporting owner

Alroy Erez

Relationship: Director
Address: C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
Signature: /s/ Marina Gofman Feler, attorney-in-fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NNOX transaction

Ordinary Shares

Sale

Transaction value: $345
Shares: -209
Change %: -3%
Price: $1.65
Shares after: 6,753
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1, F2

NNOX transaction

Ordinary Shares

Sale

Transaction value: $774
Shares: -469
Change %: -2.7%
Price: $1.65
Shares after: 17,075
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,000
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 50,000
Exercise price: $17.63
Footnotes: F4, F5

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $11.52
Footnotes: F4, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The transaction reported in this row involved the sale of ordinary shares to cover tax liabilities arising from the vesting of restricted share units ("RSUs").

Footnote F2

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on December 10, 2024. Currently, 6,753 ordinary shares constitute the remainder of the ordinary shares held by, or issuable to, the Reporting Person under the subject grant. The 7,792 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over twelve calendar quarters (for 649.33 underlying ordinary shares per quarter) such that all such 7,792 RSUs - reduced by RSUs for which underlying shares have been sold to cover tax liability - will be vested by December 10, 2027.

Footnote F3

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on December 10, 2025. Currently, 17,075 ordinary shares constitute the remainder of the ordinary shares held by, or issuable to, the Reporting Person under the subject grant. The 17,544 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over twelve calendar quarters (for 1,462 underlying ordinary shares per quarter) such that all such 17,544 RSUs - reduced by RSUs for which underlying shares have been sold to cover tax liability - will be vested by December 10, 2028.

Footnote F4

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F5

The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the date of appointment of the Reporting Person to the Issuer's Board of Directors on June 30, 2022, such that all options reported in this row will be exercisable by the four-year anniversary of that appointment date (June 30, 2026).

Footnote F6

The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable by the four-year anniversary of that grant approval date (August 14, 2027).